Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024
Operating activities
Net income (loss)	$ 93,511,000	$ (113,491,000)
Adjustments to reconcile net income to cash provided by operating activities:
Goodwill impairment	0	162,000,000
Provision for bad debts	1,001,000	3,415,000
Deferred tax expense (benefit)	6,748,000	(7,279,000)
Depreciation and amortization	19,923,000	29,015,000
Amortization of developed technology and backlog	11,713,000	10,918,000
Amortization of debt discount and issuance costs	4,407,000	4,652,000
Gain on extinguishment of debts, net	(14,207,000)	0
Equity-based compensation	11,343,000	6,851,000
Change in fair value of contingent consideration	1,014,000	(271,000)
Warranty provision	10,290,000	36,000
Inventory reserve	3,360,000	2,481,000
Other non-cash	(2,017,000)	0
Changes in working capital, net	(88,941,000)	(1,933,000)
Net cash provided by operating activities	58,145,000	96,394,000
Investing activities
Purchase of property, plant and equipment	(14,496,000)	(5,604,000)
Acquisition, net of cash acquired	(164,916,000)	0
Retirement/disposal of property, plant and equipment	0	38,000
Sale of equity investment	0	11,975,000
Net cash (used in) provided by investing activities	(179,412,000)	6,409,000
Financing activities
Proceeds from issuance of other debt	108,659,000	19,024,000
Proceeds from issuance of convertible notes	345,000,000	0
Premium paid on capped call	(35,087,000)	0
Fees paid on issuance of convertible notes	(10,434,000)	0
Repayments of other debt	(119,181,000)	(24,879,000)
Repayments of term loan facility	(233,875,000)	(3,225,000)
Repayments of convertible notes	(78,363,000)	0
Contingent consideration payments	(1,204,000)	(1,427,000)
Other financing	(1,033,000)	(1,734,000)
Net cash used in financing activities	(25,518,000)	(12,241,000)
Effect of exchange rate changes on cash and cash equivalent balances	5,747,000	(7,270,000)
Net change in cash and cash equivalents and restricted cash	(141,038,000)	83,292,000
Cash and cash equivalents, and restricted cash beginning of period	364,141,000	249,080,000
Cash and cash equivalents and restricted cash, end of period	$ 223,103,000	$ 332,372,000